Filing Flows › Industries › Industrials › Laboratory Analytical Instruments
Laboratory Analytical Instruments SIC 3826
24 companies filing with the SEC under SIC 3826. Median revenue growth +6% year on year in Q2 2026 (middle half -1% to +16%, 23 companies). The growth model expects the industry's combined revenue to grow +12% in Q3 2026. 11 customer or supplier links named in annual reports.
Money flow: where the industry's revenue goes
Drawn in the browser: an estimate of where the industry's revenue goes — what it buys from other industries, the pay that reaches households, taxes and profit — beside its filed cash flow, two tiers of suppliers and its capital spending by kind of asset.
Open the industry: growth distribution, money flow, network →
Who sells to whom
Customers and suppliers named in the companies' annual reports; the share is of the supplier's revenue.
- EYPT → ANIP 40% of the supplier's revenue, $12.7M
- PRPO → Medicare & Medicaid 40% of the supplier's revenue, $9.6M
- ILMN → TEM
- ILMN → NTRA
- ILMN → WGS
- ILMN → GH
- ILMN → FLGT
- ILMN → GRAL
- ILMN → CAI
- AVTR → ESTA
- BIO → IMDX
Growth model
Industry revenue, the same companies year on year; 80% ranges. Fitted on SEC filings and tested out of sample (how).
| Quarter | Growth Y/Y | Revenue | 80% range |
|---|---|---|---|
| Q3 2026 | +12.4% | $10.1B | $9.4B – $10.8B |
| Q4 2026 | +11.1% | $10.6B | $9.6B – $11.5B |
| Q1 2027 | +10.1% | $10.1B | $9.1B – $11.1B |
| Q2 2027 | +9.2% | $10.9B | $9.8B – $12.0B |
Capital spending and supply chain →
Companies
| Company | Quarterly revenue | Y/Y | Stage |
|---|---|---|---|
| A Agilent Technologies | $1.9B | +8% | mature |
| WAT Waters | $1.8B | +113% | expansion |
| AVTR Avantor | $1.7B | +0.5% | mature |
| ILMN Illumina | $1.1B | +9% | mature |
| MTD Mettler Toledo International | $1.1B | +4% | mature |
| BRKR Bruker | $874M | +5% | mature |
| RVTY Revvity | $729M | +1% | deceleration |
| BIO Bio-Rad Laboratories | $656M | -0.1% | mature |
| TXG 10x Genomics | $151M | -13% | contraction |
| CTKB Cytek Biosciences | $53.2M | +6% | mature |
| PACB Pacific Biosciences of California | $40.6M | -2% | mature |
| ALMR Alamar Biosciences | $33.5M | +82% | deceleration |
| QTRX Quanterix | $32.9M | +34% | expansion |
| HBIO Harvard Bioscience | $22.7M | +11% | reacceleration |
| MASS 908 Devices | $16.1M | +23% | expansion |
| BNGO Bionano Genomics | $8.2M | +21% | reacceleration |
| RPID Rapid Micro Biosystems | $8.1M | +11% | transition |
| PRPO Precipio | $7.0M | +24% | deceleration |
| SEER Seer | $3.1M | -23% | transition |
| LCTC Lifeloc Technologies | $2.4M | +10% | reacceleration |
| SCND Scientific Industries | $1.5M | -37% | transition |
| EYPT EyePoint | $507K | -90% | transition |
| NAUT Nautilus Biotechnology | $234K | — | — |
| ASTC Astrotech | $126K | -43% | contraction |
Growth from positive, comparable quarterly revenue as filed; industries are SEC Standard Industrial Classification codes. Data Nov 8, 2026.